Covid Alert


Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2020

Volume: 10 , Issue: 1

Article Access statistics

Viewed: 119

Emailed: 0

PDF Downloaded: 94

Panacea Journal of Medical Sciences


A study of serum uric acid levels in chronic obstructive pulmonary disease


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Duggirala Pujitha Chowdary, Sankar Kalairajan*, Gerard Joseph Devadassou, Mopuru Penchala Varun

Volume : 10, Issue : 1, Year : 2020

Article Page : 36-38


Suggest article by email

Abstract

Hyperuricemia as a predictor in COPD and Exacerbation. The study aims to measure serum uric acid levels in patients with chronic obstructive pulmonary disease as a predictor.
Materials and Methods: It is an observational study done on 50 COPD patients newly diagnosed or previously diagnosed. Serum uric acid level, chest x-ray and pulmonary function tests were performed with consent.
Results: The mean normal Serum uric acid (mg/dl) was 4.86+ 1.6. The increased mean serum uric acid (Hyperuricemia) was 9.67+ 1.8. The mean serum urea and creatinine levels were 26.74+3.91 and 0.94+0.20. The FEV1% Predicted in Normal UAC – 51.8+18.6 and in cases of Hyperuricemia 53.4+16.7. FVC% Predicted in Normal UAC was 77.5+17.8 in cases of Hyperuricemia it was 76.5+18.5.
Conclusion: The outcome of our study shows serum uric acid is cost-effective, easy and non-invasive and possibly suitable in assessing the patient disease severity, progression to exacerbation.

Keywords: COPD, Serum uric acid, Hyperuricemia, Predictor.

Doi : 10.18231/j.pjms.2020.009

How to cite : Chowdary D P, Kalairajan S, Devadassou G J, Varun M P, A study of serum uric acid levels in chronic obstructive pulmonary disease. Panacea J Med Sci 2020;10(1):36-38

Copyright © 2020 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)